2m 2m 2m 2m 2m 2m 2m
SAVARA (SVRA)
NASDAQ
$5.65-$0.10 (-1.66%)
Price as of Jul 14, 2026 4:24 AM EDT- $1.2BMarket Cap
- 128.69%1-Year Change
- BiotechnologyIndustry
SAVARA (SVRA)
$5.65-$0.10 (-1.66%)
SVRA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.74 | ||
Change | -$0.29 (-4.81%) | ||
Open | $5.92 | ||
High | $5.95 | ||
Low | $5.66 | ||
Previous Close | $6.03 | ||
Volume | 1,680,566 | ||
30-Day Average Volume | 2,141,242 | ||
1-Week Change | -7.42% | ||
1-Month Change | 9.13% | ||
1-Year Change | 128.69% | ||
3-Year Change | 77.43% | ||
5-Year Change | 290.48% | ||
Fundamentals | |||
Shares Outstanding | 204.9M | ||
Total Assets | $221.6M | ||
Market Cap | $1.2B | ||
Enterprise Value | $1.2B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$37.3M | ||
Free Cash Flow | -$33.1M | ||
EBIT | -$37.3M | ||
EBITDA | -$37.3M | ||
Net Working Capital | $193.7M | ||
EPS | -$0.15 | ||
Enterprise Value/EBITDA | -33 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | -40 | ||
PEG | 3 | ||
Price/Free Cash Flow | -37 | ||
Price/Operating Cash Flow | -37 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue